Search - tctmd.com

Displaying 681 - 700 of 832

Sort: Relevancy | Date

News Industry News

Preliminary Results From the St. Jude Medical EnligHTN III Study Demonstrate Renal Denervation Is Safe and Effective

May 22, 2014

News Conference News EuroPCR 2014

Global SYMPLICITY Substudy Teases out Reasons for Non-response in Real-World Patients

Yael L. Maxwell

May 22, 2014

News Conference News EuroPCR 2014

Early Data Show Novel Catheter-Implanted Device Benefits Patients with Left Heart Failure

Caitlin E. Cox

May 22, 2014

News Industry News

St. Jude Medical Announces TOCCASTAR Clinical Trial Meets Primary Safety and Efficacy Endpoints at Heart Rhythm 2014

May 07, 2014

News Industry News

Cardiotek Announces U.S. Commercialization of the EP-Tracer System

May 07, 2014

News Industry News

St. Jude Medical Shows Commitment to Cardiac Advancements With Comprehensive Clinical Evidence Program During Heart Rhythm 2014

May 05, 2014

News Industry News

Boston Scientific Reports Key Data at the 35th Annual Scientific Sessions of the Heart Rhythm Society

May 05, 2014

News Daily News

Renal Denervation Shows Promise in Patients Refractory to Stenting

L.A. McKeown

May 02, 2014

Presentation Fellows 2014

Septal Ablation for HOCM

Presenter: Srihari Naidu

April 14, 2014

News Conference News ACC 2014

Global SYMPLICITY Registry Still Shows Positive Results for Renal Denervation

Yael L. Maxwell

March 30, 2014

News Industry News

Texas Cardiac Arrhythmia Institute at St. David's Medical Center First in the United States to Use FDA-Approved ThermoCool® SmartTouch® Catheter

March 21, 2014

News Daily News

New Valvular Heart Disease Guidelines Integrate Catheter-based Interventions

L.A. McKeown

March 20, 2014

News Daily News

Percutaneous Chemical Ablation of Cardiac Nerves Shows Promise in Treating A-fib

L.A. McKeown

February 26, 2014

News Daily News

La Ablación Química Percutánea de Nervios Cardíacos resulta Prometedora en el Tratamiento de la FA

L.A. McKeown

February 26, 2014

Presentation

Long-term Survival after Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy

Presenter: Josef Veselka

February 06, 2014

News Daily News

Survival After Septal Ablation for HOCM Similar to General Population

L.A. McKeown

February 06, 2014

News Daily News

TCTMD’s Top 10 Most Popular News Stories for 2013

Jason Kahn

January 27, 2014

News Industry News

Medtronic Begins VICTORY AF Trial of Patients with Persistent or Long-Standing Persistent Atrial Fibrillation

January 05, 2014

News Daily News

Preconditioning May Counteract Platelet Increase Associated with RF Ablation in A-fib

L.A. McKeown

December 30, 2013

News Daily News

El Preacondicionamiento Contrarrestaría el Aumento Plaquetario secundario a la Ablación RF en el Manejo de la FA

L.A. McKeown

December 30, 2013

Advertisement

Preliminary Results From the St. Jude Medical EnligHTN III Study Demonstrate Renal Denervation Is Safe and Effective

Global SYMPLICITY Substudy Teases out Reasons for Non-response in Real-World Patients

Early Data Show Novel Catheter-Implanted Device Benefits Patients with Left Heart Failure

St. Jude Medical Announces TOCCASTAR Clinical Trial Meets Primary Safety and Efficacy Endpoints at Heart Rhythm 2014

Cardiotek Announces U.S. Commercialization of the EP-Tracer System

St. Jude Medical Shows Commitment to Cardiac Advancements With Comprehensive Clinical Evidence Program During Heart Rhythm 2014

Boston Scientific Reports Key Data at the 35th Annual Scientific Sessions of the Heart Rhythm Society

Renal Denervation Shows Promise in Patients Refractory to Stenting

Septal Ablation for HOCM

Global SYMPLICITY Registry Still Shows Positive Results for Renal Denervation

Texas Cardiac Arrhythmia Institute at St. David's Medical Center First in the United States to Use FDA-Approved ThermoCool® SmartTouch® Catheter

New Valvular Heart Disease Guidelines Integrate Catheter-based Interventions

Percutaneous Chemical Ablation of Cardiac Nerves Shows Promise in Treating A-fib

La Ablación Química Percutánea de Nervios Cardíacos resulta Prometedora en el Tratamiento de la FA

Long-term Survival after Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy

Survival After Septal Ablation for HOCM Similar to General Population

TCTMD’s Top 10 Most Popular News Stories for 2013

Medtronic Begins VICTORY AF Trial of Patients with Persistent or Long-Standing Persistent Atrial Fibrillation

Preconditioning May Counteract Platelet Increase Associated with RF Ablation in A-fib

El Preacondicionamiento Contrarrestaría el Aumento Plaquetario secundario a la Ablación RF en el Manejo de la FA

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content